drugset
drugset / Trial / NCT00647231

HKT-500-US12 In Adult Patients With OA Knee Pain

NCT00647231 ↗

Phase 2 Completed 300 enrolled Hisamitsu Pharmaceutical Co., Inc.
RandomizedFactorialQuadruple-blind

Summary

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Timeline

Start
2008-03
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule — Topical

Indications

osteoarthritis, knee